Indiana § 25-26-14-21.5 Prohibitions; sanctions

Indiana Statutes

§ 25-26-14-21.5 — Prohibitions; sanctions

Indiana § 25-26-14-21.5

Title 25PROFESSIONS AND OCCUPATIONS

Art. 26PHARMACISTS, PHARMACIES, DRUG STORES

Ch. 14Wholesale Legend Drug Distributors and Third Party

This text of Indiana § 25-26-14-21.5 (Prohibitions; sanctions) is published on Counsel Stack Legal Research, covering Indiana primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ind. Code § 25-26-14-21.5 (2026).

Text

5.

(a)A person may not perform, cause the performance of, or aid the performance of the following:

(1)The manufacture, repackaging, sale, delivery, holding, or offering for sale of a legend drug that is adulterated, misbranded, counterfeit, suspected counterfeit, or is otherwise unfit for distribution.

(2)The adulteration, misbranding, or counterfeiting of a legend drug.

(3)The receipt of a legend drug that is adulterated, misbranded, stolen, obtained by fraud or deceit, counterfeit, or suspected counterfeit, and the delivery or proffered delivery of the legend drug for pay or otherwise.

(4)The alteration, mutilation, destruction, obliteration, or removal of the whole or a part of the labeling of a legend drug or the commission of another act with respect to a legend drug that results

Free access — add to your briefcase to read the full text and ask questions with AI

5. (a) A person may not perform, cause
the performance of, or aid the performance of the following:
(1) The manufacture, repackaging, sale, delivery, holding, or
offering for sale of a legend drug that is adulterated, misbranded,
counterfeit, suspected counterfeit, or is otherwise unfit for
distribution.
(2) The adulteration, misbranding, or counterfeiting of a legend
drug.
(3) The receipt of a legend drug that is adulterated, misbranded,
stolen, obtained by fraud or deceit, counterfeit, or suspected
counterfeit, and the delivery or proffered delivery of the legend
drug for pay or otherwise.
(4) The alteration, mutilation, destruction, obliteration, or removal
of the whole or a part of the labeling of a legend drug or the
commission of another act with respect to a legend drug that
results in the legend drug being misbranded.
(5) Forging, counterfeiting, simulating, or falsely representing a
legend drug using a mark, stamp, tag, label, or other identification
device without the authorization of the manufacturer.
(6) The purchase or receipt of a legend drug from a person that is
not licensed to distribute legend drugs to the purchaser or
recipient.
(7) The sale or transfer of a legend drug to a person that is not
authorized under the law of the jurisdiction in which the person
receives the legend drug to purchase or receive legend drugs from
the person selling or transferring the legend drug.
(8) Failure to maintain or provide records as required under this
chapter.
(9) Providing the board, a representative of the board, or a state
or federal official with false or fraudulent records or making false
or fraudulent statements regarding a matter related to this chapter.
(10) The wholesale distribution of a legend drug that was:
(A) purchased by a public or private hospital or other health
care entity;
(B) donated or supplied at a reduced price to a charitable
organization; or
(C) stolen or obtained by fraud or deceit.
(11) Obtaining or attempting to obtain a legend drug by fraud,
deceit, misrepresentation, or engaging in fraud, deceit, or
misrepresentation in the distribution of a legend drug.
(12) Failure to obtain, authenticate, or provide a required
pedigree.
(13) The receipt of a legend drug through wholesale distribution
without first receiving a required pedigree attested to as accurate
and complete by the wholesale drug distributor.
(14) Distributing a legend drug that was previously dispensed by
a retail pharmacy or distributed by a practitioner.
(15) Failure to report an act prohibited by this section.
(b) The board may impose the following sanctions if, after a hearing
under IC 4-21.5-3, the board finds that a person has violated subsection
(a):
(1) Revoke the wholesale drug distributor's license issued under
this chapter if the person is a wholesale drug distributor.
(2) Assess a civil penalty against the person. A civil penalty
assessed under this subdivision may not be more than ten
thousand dollars ($10,000) per violation.